Peer Review History
| Original SubmissionApril 30, 2020 |
|---|
|
PONE-D-20-06779 Assessing Service Availability and Readiness to manage Chronic Respiratory Disease (CRD) in Bangladesh PLOS ONE Dear Dr. Paromita, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers have provided a number of comments and suggestions regarding how the methods are described as well as the flow of the paper. Please consider carefully these comments and provide point-by-point responses on how the comments were addressed. Please submit your revised manuscript by Oct 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, David Hotchkiss Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Please include a copy of Table 1 which you refer to in your text on page 7. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Respiratory Disease(CRD) management is an important step for medical care services. This manuscript is well written and pointed out an important gap to be filed to ensure proper CRD management. In the discussion authors suggested some guidelines, it would be good to see an additional point on Patient-Based Simulation Training. They can cite Cohen et al., 2014. PMID: 24492338, DOI: 10.1097/SIH.0000000000000009 The overall quality and scientific findings meet the standard criteria for Plos One journal publications. I recommend to accept the manuscript for publishing. Reviewer #2: 1. While the analysis is technically correct, the criteria for readiness are applied equally to all levels of facilities. However, lower level facilities would not be expected to provide the same level of services or have the same level of equipment and medicines as higher level facilities. The analysis should be revised to take into account the level of services expected or required at different levels of facilities. 3. There is no comment on the availability of data. The authors should state where or how the data could be accessed. 4. There are two versions of the manuscript provided. The second version is longer but superior to the first version, and my comments apply to the second version. Although the language in the second version is much better than in the first, a review for grammar and syntax is advised. eg line 60 prevailing should be prevalent. line 68 sector not sectors etc. Further comments follow: Introduction: It would be useful to describe here the organization of health facilities in Bangladesh, to assist in understanding the description in the methods section - which facilities are located at which administrative level, and population served; and to describe the two administrative wings of the MOH - health services and family planning. A brief description of the geographic organization would also assist as a basis for understanding the ‘divisions’ described in Table 2 eg a map and populations per division. Methods: More detailed description of the SARA methodology and sampling is provided compared to version 1 - which strengthens the paper. Table 2 Would it be possible to include the total number of each level of facility as well as the number sampled, to provide a comparison with the sample size, and the extent to which it is representative of the distribution of facilities, at least for the public facilities. Results P10 line 162 ‘provided service’ – replace with ‘reported providing the service’ since the survey did not actually determine if the service was provided. Figure 2 not required Discussion Some comment on the extent to which the sample is representative of facilities in Bangladesh is required. It would appear that the survey assessed the same criteria for each level of service, with the same list of staffing, equipment, diagnostic facility and medicines. However, this does not take into account the particular services provided at each level of the health system. For example, it would not be expected that and FWC / community clinic could undertake spirometry, or would have a physiotherapist on staff. It is recommended that the criteria for readiness be adjusted based on the services for CRD that are expected to be provided at each level, and then assess facilities at each level against the relevant criteria ? A further limitation is that the data is based on reported information from the interviewed staff member, and was not confirmed by observation. This should be mentioned in limitations, as well as comment on the accuracy of the data collected by interview. Conclusions Rather than expect all services to be available at all levels, it would be important to develop a flow chart indicating what services should be provided at which level, and where referral to a higher level is needed for further care / investigation. Additional resources should then be provided to the level of facility that constitutes the greatest gap between required facilities and those reported. Reviewer #3: Thank you for the opportunity to review this informative paper.This is an important issue, and I congratulate the authors for bringing further attention to it. The paper aimed to explore service availability and readiness at all tier of facilities in Bangladesh by using standard tool prepared by WHO. However, I have some slight amendments authors may wish to consider to improve the quality of the paper. General comments The topic is interesting and important for reducing the burden of CRD in LMIC. However, the manuscript needs extensive revision. The Introduction section missing a proper flow resulted to poor framing of research questions. In Methods, the sampling procedure and how the sample size has been derived is not clear. There is some redundancies of results in the Discussion section. Finally, the conclusion needs to be revised. If the authors revised these areas probably they would have a good article. Below are my comments --Abstract: 1. Generally, the flow of the abstract is not well structured, therefore, authors needs to revise it for clear understanding. 2. WHO SARA needs to be spelled out. 3. Methods; the second sentence “We collected data …….” Is not clear, authors need to revise it. 4. The last sentence not clear. What are the four domains? How availability and readiness index were calculated? 5. Results; only three out of two hundred facilities had adequate capacity……… it is not clear because in methods the total facilities were 537. What is RI mean? 6. The second sentence “Rests of ……….” Is not clear, what authors meant by far away from cut off value? How was it decided? 7. Conclusion; “………….only tertiary care hospitals………” this sentence is not true based on results. Authors should check it clearly. The conclusion does not tile with results. --Introduction: 1. This Introduction section has rich of information, however, the flow is not proper i.e the authors should start and complete all information at Global level, then go to LMIC and then Bangladesh. Mixing and jumping of ides have observed in this section (for example; paragraph 1 included information from global, LMIC, and developed countries; paragraph 2 global and Bangladesh, and etc.). 2. 2nd and 3rd paragraph authors explained much about NCD rather than CRD which is the aim of this study. 3. Poor linking of information of NCD to CRD and availability of services/service provision made the authors failed to focus on the topic which lead to unclear explanation of their research question(s). --Methods: 1. Generally, this section is not well structured. 2. Study design most information do not fall under this subsection. For example, training of interviewers, data collection and entry, and etc. 3. Sample size/ sampling technique; rather than providing the references the authors are required to explain in details the sample size calculation as well as sampling procedures. 4. Data analysis; surprisingly, most of the information written here not telling us how authors analyzed data. The details here are very vague and makes difficult to follow. 5. How the cut-off point of 70% reached? Is it based on the authors’ agreement without considering previous literature? If yes, why the authors did not choose to be 80% or 90% or 60%? 1. Ethical statement; This part is missing in the current version. --Results: 1. CRD service availability; the text does not tile with the Figure 1 and 2. 2. CRD service readiness; what is the unit of readiness score? 2nd sentence “….. only 6 tertiary level hospitals out 537 were ready………” the use of 537 facilities in sentence is wrong or the comparison is wrong. The sentence is very confusing. 3. Missing of n in the all figures makes difficult to interpret data. 4. In all figures the test for significance is missing. Therefore, it is difficult to establish the statistical significance of the results. --Discussion: 1. Generally, the discussion is not well written and the authors failed to discuss in detail the important findings from this study instead they summarized and presented the findings shown in the results section. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Krishna Philip Hort Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-06779R1 Assessing Service Availability and Readiness to manage Chronic Respiratory Disease (CRD) in Bangladesh PLOS ONE Dear Dr. Paromita, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As you will, see the reviewer who re-reviewed the manuscript still has a number of comments on the calculation of the indicators used in the analysis, as well as on the use of English. In addition, I should note that there are still discrepancies in the track changes version and the clean version of the manuscript, which made it difficult to review of manuscript. Please submit your revised manuscript by Jan 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, David Hotchkiss Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: There are two versions of the revised paper: a first version commencing on page 19 immediately following the responses to reviewers and a second version headed ‘revised manuscript with track changes’ commencing on page 50. Unfortunately, while the authors have inserted Table 1 into the revised first version of R1, there is still a discrepancy in lines 221 following in the first version: The first version of the paper is as follows: 221 The strength of this study is that we explored the current scenario of CRDs management in 222 facilities throughout Bangladesh stratified by different levels. We explained it both in summarized 223 and disaggregated in all four domains according to WHO SARA Standard Tool. However, there 224 are few limitations such as we could not include all the sample health facilities due to incomplete 225 questionnaire and absence of proper interviewee. Also,changes over time could not be observed 226 as it is a cross-sectional study. The available data only reflects on the snapshot of availability and 227 readiness. The second version of the paper has the following paragraph at the end of the discussion section in the same position as the paragraph above: 228 The strength of this study is that we explored the current scenario of CRDs management in 229 facilities throughout Bangladesh stratified by different levels. We explained it both in 230 summarized and disaggregated in all four domains according to WHO SARA Standard Tool. 231 However, there are few limitations such as we could not include all the sample health facilities 232 due to incomplete questionnaire and absence of proper interviewee. Data is based on reported 233 information from the interviewed staff member and was not confirmed by observation.Moreover, 234 we had to use same indicators for all level of facilities as there is no specific evidence 235 mentioning what services should be provided at which level. Also, changes over time could not 236 be observed as it is a cross-sectional study. The available data only reflects on the snapshot of 237 availability and readiness. The second version, while not marked in track changes, contains the changes requested in the review, and should replace the same paragraph in the first version. Responses to questions in the review of the first version of the paper Q1. Criteria applied to all levels of facilities. I note the response to my question on different criteria for different levels of facilities: ‘we have used the same indicators for all levels of facilities’. However, even if facilities could not be distinguished on the basis of what services should be offered at what level, calculation of readiness should also take into account whether the facilities claims to offer the service. However, the availability calculations in this paper appear to be calculated on the basis of all facilities at each level (Table 3 n values) .The WHO SARA guidelines explain that availability should only be calculated on the facilities offering the services. As the proportion of facilities offering the service (reported as availability) was much lower among MCWC and FWC/CCs, the calculation of readiness will be significantly altered. See reference below: https://www.who.int/healthinfo/systems/SARA_Implementation_Guide_Chapter8.pdf?ua=1 SARA Implementation guide: page 113 Step 3. Calculate the mean availability of each tracer item The mean availability of each tracer item is equal to the total number of facilities that have the tracer item available (i.e. value=1), divided by the total number of facilities OFFERING THE SERVICE, multiplied by 100 to get a percentage value. The authors need to address this issue. If the authors choose not to use the SARA guidelines in the calculations, this should be explained; otherwise the calculations need to be repeated based only on facilities that claim that they offer CRD services. Note that if the readiness scores are calculated based on facilities offering CRD services, then the comments in the discussion lines 212-217 may need to be revised – as the MCWC and FWC facilities also have low proportions who claim to offer CRD services. Q3 addressed Q4 There are still issues with syntax and grammar -see errors identified below Responses to comments Comments on methods (1) Additional information on facilities sampled: The response does not address the issue of additional information on facilities except very briefly. It does not indicate the population served by each facility. Given the very large populations in Bangladesh, it is important that readers understand that a UHC serves a population greater than many districts in other countries. I would recommend a table as initially suggested with average populations per level of health facility. Methods Table 2 This indicates the % of facilities in the sample, but does not indicate the total number of facilities in the country, so that the sample as a percentage of total facilities can be calculated. This data should be available from the main study. If so a reference to a published paper of the main study would be sufficient to cover this, although inclusion of the data would be preferable. Line 119-123 states that a selection of facilities was made for the SARA parent study. Please state briefly how facilities were selected. (2) Comments on results This point has been adequately addressed (3) Comments on discussion See comments above on calculations of service readiness above. This comment has not been adequately addressed. Comment 2 has been adequately addressed (4) Comments on conclusions This comment was addressed in the limitations. However I note that although these changes are noted in the version of the report labelled ‘track changes’ – these changes are not included in the version of the report that appears to be the final revised version. Table 1, although referred to in the revised version, is not included, although included in the track changes version. Corrections to syntax Line 68 health sector (singular) Line 96 add ‘the’ WHO SARA standard tool Line 98 – reduce ‘by’ one third Line 110 – add ‘The’ WHO SARA standard tool Line 118 – add hospitals ‘and health centres’ Line 124 and following – there is a reference only to hospitals eg ‘the head of each hospital’ – but the survey includes non hospital facilities – suggest replace the word hospital here with facility Line 134 – ‘and enter data’ – add ‘to’ – and to enter data. Line 173 – add ‘facility’ – only facility to cross Line 197 – replace ‘pick’ with ‘peak’ Line 206 – replace ‘true’ with ‘found’ Line 221 - replace ‘few’ with ‘some’ and add ‘to this study’ – there are some limitations to this study Line 226 – separate Bangladeshis – to ‘Bangladesh is’ ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Krishna Hort [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Assessing Service Availability and Readiness to manage Chronic Respiratory Disease (CRD) in Bangladesh PONE-D-20-06779R2 Dear Dr. Paromita, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, David Hotchkiss Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Krishna Hort |
| Formally Accepted |
|
PONE-D-20-06779R2 Assessing service availability and readiness to manage Chronic Respiratory Diseases (CRDs) in Bangladesh Dear Dr. Paromita: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. David Hotchkiss Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .